AB-BIOTICS and H&H Group partner to launch a new premium probiotic for babies and toddlers

Biostime is designed for babies aged zero months and up, to toddlers aged three years

Kaneka’s probiotics and microbiome science affiliate, AB-BIOTICS, has launched a new nutritional supplement for infants in collaboration with global health and wellness company, H&H Group. The new Biostime probiotic formula is designed to support health gut microbiota in infants. The latest addition to the Biostime range is will be made available across Asia-Pacific and the US.

Biostime Vitamin D + Probiotic Drops are designed for babies aged zero months up to toddlers aged up to three years. The drops include Bifidobacterium longum CECT 7894 and Pediococcus pentosaceus CECT 8330, which, when used in combination, support healthy microflora balance, which is correlated with decreased crying time in colicky infants*.

AB-BIOTICS APAC regional manager, Albert Royo, said: “We’re delighted to announce the launch of this supplement under the Biostime brand — the fruits of our partnership with H&H Group. Bringing together our collective scientific expertise, market knowledge and application know-how, we have developed an effective, appealing and accessible market-ready product that can contribute to babies’ health. We look forward to working on other projects with Biostime.”

Hanno Cappon, chief technology officer at H&H Group, added: “Microbiome health is one of the cornerstones of our expertise at H&H Group, demonstrated by Biostime achieving the top Probiotics and Prebiotics brand worldwide in the pediatric field. Our H&H Research team focuses on identifying the best ‘biotic’ ingredients to develop effective, evidence-based supplements for our consumers across all life stages. The best innovations we find come through partnerships and co-development with other expert companies in the industry. This is a fantastic example of collaboration inspired by exciting science; this Vitamin D + Probiotic drops product is a great addition to our Biostime portfolio.”

*These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.